CV- ELI SCHWARTZ, MD, DTMH

LIST OF PUBLICATIONS-according to subjects (partial list)

Parasitic Diseases

Malaria:

1. Schwartz E., Golenser Y. Treatment of malaria. Harefu'ah, 124, 572-577, 1993.

2. Duer D., Schwartz E., Shaked N., Ramot B. Amodiaquin-induced agranulocytosis: Drug inhibition of myloid colonies in the presence of patient's serum. . J. of Medical Science. 21: 331-334, 1985.

3. Schwartz E., Shapiro R., Shina S., Bank, I. Delayed Expansion of Vδ2+ and Vδ1+ γδ T cells after acute Plasmodium falciparum and Plasmodium vivax malaria. J. of Allergy and Clinical Immunology 97, 1387-1392, 1996.

4. Schwartz E., Pener H., Issa M.S., Golenser J. An overview of the malaria situation in Zanzibar. J. of Community Health 22, 33-44, 1997.

5. Golesner J., Peled-Kamar M., Schwartz E., Friedman H., Groner Y., Pollack Y. Transgenic mice with elevated level of CuZnSOD are highly susceptible to malaria infection. Free Radicals Biology and Medicine .24,1504-1510,1998.

6. Schwartz E., Sidi. Y. New aspects of malaria imported from . Clinical Infectious Disease.26, 1089-1091, 1998.

7. Weber G., Schwartz E., Schlaffer F., Lang R., Alkan M. Imported severe Plasmodium falciparum malaria in Israel. J. of Travel Medicine. 5, 97-99, 1998.

8. Schwartz E., Samuni A., Friedman I., Hempelmann E., Golenser Y. Deleterious role of superoxide dismutation in malaria parasites. Inflamation .23: 361-370, 1999.

-1 - Short CV- ELI SCHWARTZ, MD, DTMH

9. Schwartz E., Regev-Yochay G., Primaquine as prophylaxis for malaria for non-immune travelers; comparison to mefloquine or doxycycline Clinical Infectious Disease. 29, 1502-1506, 1999

10. Schwartz E., Regev-Yochay G., Kurnik D. Considering primaquine dose adjustment for radical cure of Plasmodium vivax malaria. American . J. of Tropical Medicine and Hygiene. 62, 393-5, 2000

11. Schwartz E., Paul F., Pener H., Almog S., Rotenberg M., Golenser J. Malaria antibodies and mefloquine levels among troops in . J. Travel Medicine. 8:113-116, 2001

12. Schwartz E. ,Potasman I.., Rotenberg M., Almog S., Sadetzki S. Serious adverse events of mefloquine in relation to blood level and gender. American . J. of Tropical Medicine and Hygiene. 65;189-192,2001

13. Schwartz E. Sadetzki S Murad H,. Raveh D. Age as risk factor for severe malaria. Clinical Infectious Diseases. 33; 1774-7, 2001

14. Schwartz E. Primaquine for malaria prophylaxis. In Travelers’ Malaria (P. Schlagenhauf Editor) B C Decker Inc. Canada, 2001 (Revised 2007)

15. Potasman I, Yuven Y, Weller B, Heidecker J, Schwartz E. Does Mefloquine Prophylaxis Affect Electro-Encephalographic Patterns? American J. of Medicine, 112:147-149 , 2002

16. Schwartz E., Malaria in Israel- Can we prevent the severe morbidity and mortality ? Harefua- (Editorial)- 141: 699-701, 2002

17. Bujanover S, Schwartz E., Rapid test for Malaria Isr Med Assoc J. 4; 1167: 2002

18. Schlagenhauf P., Tschopp A., Johnson R., Nothdurft HD,Beck B., Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Steffen R. Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan Africa: a randomised, double-blind, four-arm study. Br. Med. J. – 327;1078-1083, 2003

19. Schwartz E ,Bujanover S.,Kain K Genetic Confirmation of Atovaquone–proguanil (Malarone™) resistant Plasmodium falciparum malaria acquired by a non-immune traveler to East Africa.

-2 - Short CV- ELI SCHWARTZ, MD, DTMH

Clinical Infectious Diseases- 37; 450-1, 2003

20. Eli Schwartz, Praise M., Kozarsky P, Cetron M. Delayed onset of malaria: Implications for chemoprophylaxis in travelers. New Engl. J. Med.- 349: 1510-6, 2003

21. Elliott JH, O’Brien D, Leder K, Kitchener S, Schwartz E, Weld L, Brown GV, Torresi J. for the GeoSentinel Surveillance Network. Imported Plasmodium vivax malaria: demographic and clinical features in non-immune travellers J. of Travel Medicine -11:213-219, 2004

22. Leder K, Black J, O’Brien D, Greenwood Z, Kain K, Schwartz E., Brown G, Torresi J. Malaria in travelers: a review of the GeoSentinel Surveillance Network. Clinical Infectious Diseases- 39:1104-12, 2004

23. Schwartz E. Malaria – a disease that refuses to die but continues to kill.[Editorial] Isr Med Assoc J. 2005

24. Baird K, Schwartz E, Hoffman S. Prevention and treatment of vivax malaria. Curr Infect Dis Rep. 9(1):39-46, 2007

25. Schlagenhauf, P, Johnson R, Schwartz E, Nothdurft HD, Steffen R. Evaluation of mood profiles during malaria chemoprophylaxis : a randomised, double-blind, four-arm study. J. Travel Med- - 16(1):42-5, 2009

26. E Kopel, E Schwartz, Z Amitai, I Volovik Relapsing vivax malaria cluster in Eritrean refugees, Israel June 2010. Eurosurveillance, Volume 15, Issue 26, 01 July 2010.

27. Sabbag A, Schwartz E. The awareness of malaria in primary care medicine]. Harefuah. 2010 Sep;149(9):568-71, 621, 620. Hebrew.

28. Altman A, Gueta I, Grosman T, Schwartz E. Acute respiratory distress syndrome (ARDS) as a complication of malaria P.vivax]. Harefuah. 2010 Sep;149(9):580-2, 620. Hebrew.

29. Neuberger A, Zaolan O, Tenenboim S, Vernet S, Pex R, Held K, Urman M, Garpenfeldt K, Schwartz E . Malaria among patients and aid workers consulting a primary healthcare center in

-3 - Short CV- ELI SCHWARTZ, MD, DTMH

Leogane, Haiti, November 2010 to Febuary 2011 – a prospective observational study. Eurosurveillance, Volume 16, Issue 13, 31 March 2011

30. Eyal leshem, Nathan Keller, Daphna Guthman, Tamar Grossman,Michal Solomon, Esther Marva, Eli Schwartz False Positive Plasmodium falciparum Histidine-Rich Protein 2 Immunocapture Assay in Acute Schistosomiasis Caused by Schistosoma mekongi J. Clin. Micrbiol. 49(6):2331-2, 2011

31. Eran Kopel, Enbal Marhoom Yechezkel Sidi and Eli Schwartz Successful oral therapy for severe falciparum malaria: The World Health Organization criteria revisited Am J Trop Med Hyg. 2012

Schistosomiasis:

32. Schwartz E. Rozenman J, .Perelman N. Pulmonary manifestations of early schistosoma infection among nonimmune travelers. American J. of Medicine 109, 718-722, 2000.

33. Schwartz E. Pulmonary Schistosomiasis Clinics in Chest Medicine, 23; 433-443, 2002

34. Schwartz E. Rozenman J. Schistosomiasis N. Engl. J. Medicine, 347;766-768, 2002

35. Schwartz E, Pick N, Shazberg G, Potasman I, Hematospermia Due to Schistosome Infection in Travelers: Diagnostic and Treatment Challenge. Clinical Infectious Diseases. 35;1420-4, 2002

36. Schwartz E. Hematospermia caused by schistosomiasis in travelers [Clinical Insights, Contemporary Topics]. MD Consult Infectious Disease. November 3, 2003. Available at: http://www.mdconsult.com

37. Schwartz E., Kozarsky P, Wilson M, Cetron MD. Schistosome infection among river rafters on the Omo River, Ethiopia J. of Travel Medicine – 12: 3-8, 2005.

-4 - Short CV- ELI SCHWARTZ, MD, DTMH

38. Meltzer E, Artom G, Marva E , Assous M, Rahav G , Schwartz E. Schistosomiasis in travelers - new aspects of an old disease Emerging Infectious Diseases. 12; 1696-1700, 2006

39. Schwartz E. Lung Involvement in schistosomiasis (Chapter) In: Om P. Sharma ed. Tropical Lung Disease 2nd edition Taylor & Francis Group. New York, 2006

40. Meltzer E, Schwartz E. Enteric fever: an Israeli perspective (Review) Isr Med Assoc J. 9:736–741, 2007

41. Nicolls DJ., Weld L, Schwartz E , Reed C, Sonnenburg F, Kozarsky P, for the GeoSentinel Surveillance Network Schistosomiasis in Travelers: a review of patients reported to the GeoSentinel Surveillance Network. Am J Trop Med Hyg.79(5):729-34, 2008

42. Leshem E, Maor Y, Meltzer E, Assous M, Schwartz E. Acute schistosomiasis outbreak: clinical features and economic impact. Clin Infect Dis. 15;47(12):1499-506, 2008

43. Leshem E, Meltzer E, Marva E, Schwartz E, Travel-Related Schistosomiasis Acquired in Laos Emerging Infectious Diseases..15(11):1823-6. 2009

Leishmania & Myiasis:

44. Schwartz E., Gur H D. hominis Myiasis Among Israeli Travelers to South America: An Emerging Disease in the Amazon Basin of Bolivia. J. of Travel Medicine 9: 97-99, 2002

45. Tamir J., Haik J., Orenstein A., Schwartz E., Dermatobia Hominis Myiasis among travelers returning from South America. J. American academy of Dermatology- 48: 630-632; 2003

46. Scope A, Trau H, Andreas G., Konfino Y., Barzilay A., Schwartz E. Experience with New World Cutaneous Leishmaniasis in Israeli Travelers. J. Am Acad Dermatol- 49: 672-8, 2003

-5 - Short CV- ELI SCHWARTZ, MD, DTMH

47. Scope A, Trau H, Bakon M, Yarom N, A. Nasereddin. Schwartz E. Imported Mucosal Leishmaniasis in a Traveler Clinical Infectious Diseases- 37: e83-7, 2003

48. Jeremy Tamir, Josef Haik, Eli Schwartz, Myiasis with Lund's fly (Cordylobia rodhaini) in Travelers. J. of Travel Medicine - 10:293-5, 2003

49. Blum J, Desjeux Ph., Schwartz E., Beck B., Hatz Ch. Treatment of cutaneous leishmaniasis. J. Antimicrobial Chemotherapy-53, 158-66,2004

50. Shani Adir A, Rozenman D, Kamil S, Schwartz E., Ramon M, Zalman L, Nasereddin A, Jaffe CL, Ephros M. Leishmania tropica in northern Israel– a clinical overview of an emerging focus J. American academy of Dermatology -53, 810-15,2005

51. Eli Schwartz Leishmaniasis in Israel (Editorial) J. Israeli Military Medicine, 2005

52. Schwartz E., Hatz C, Blum J. New World Cutaneous Leishmaniasis in Travellers The Lancet Infectious Diseases; 6:342-9, 2006

53. Solomon M, Baum S, Barzilai A , Scope A, Trau H, Schwartz E Liposomal Amphotericin B in comparison to Sodium Stibogluconate for Treatment of Cutaneous Leishmaniasis due to L. Braziliensis J. American academy of Dermatology –56;612-616, 2007

54. Bar Daroma E, Wilamowski A, Schnur H, Yarom N, Scheuer E, Schwartz E. Oral Myiasis:A case report and literature review Oral Surg Oral Med Oral Pathol Oral Radiol Endod.- 103; 92-6, 2007

55. Solomon M, , Trau H, Schwartz E Old-World cutaneous leishmanisis: An ancient disease in wait of new drug Annales de dermatologie et de venereologie, 135; 357-359, 2008

56. Solomon M, Baum S, Barzilai A , Pavlotzki F, Trau H, Schwartz E. Treatment of cutaneous Leishmaniasis with Intralesional Pentostam in Israel J Eur Acad Dermatol Venereol. (10):1189-92. 2009

57. Solomon M, , Pavlotzki F, Leshem E, Ephros M, Trau H, Schwartz E Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania Tropica J Eur Acad Dermatol Venereol.-2010

-6 - Short CV- ELI SCHWARTZ, MD, DTMH

Others:

58. Schwartz E., Shlim D.R. Tick bite appendicitis (Case report). J. of the American Medical Association. 259,24: 3561, 1988.

59. Houston R., Schwartz E. Helmenthic infection among Peace Corp volunteers in Nepal. J. of the American Medical Association. 263, 373-374, 1990.

60. Schwartz E., Houston R. The effect of co-trimoxazole on stool recovery of Blastocystis hominis. Lancet, 339, 428-429, 1992

61. Meltzer E., Perchik R, Shatzkes J. Sidi Y. Schwartz E. Eosinophilia among returning travelers – a practical approach American . J. of Tropical Medicine and Hygiene – 2008 ;78(5):702-9

62. Leshem E, Kliers I, Bakon M, Zucker T, Potasman I, Schwartz E. Neurocysticercosis in Israel] Harefuah. 2010 Sep;149(9):576-9, 620. Hebrew.

63. Leshem E, Kliers I, Bakon M, Gomori M, Karplus R, Schwartz E. Neurocysticercosis in travelers: a nation-wide study in Israel. J Travel Med. 2011 May-Jun;18(3):191-7

64. Meltzer E., Steinlauf S, Michaeli S, Leshem E, Sidi Y, Schwartz E Human African Trypanosomiasis in a traveler: diagnostic pitfalls. Am J Trop Med Hyg. 2012

Viral Infection

Dengue fever:

65. Schwartz E., Mendelson E., Sidi Y. Dengue fever among travelers. American J. of Medicine 101, 516-520, 1996.

66. Potasman I., Srugo I., Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerging Infectious Diseases.5, 824-7,1999.

-7 - Short CV- ELI SCHWARTZ, MD, DTMH

67. Schwartz E., Mileguir F., Grossman Z., Mendelson E . Evaluation of serological-based diagnosis of dengue fever among travelers. J. Clin. Virology. 19, 169-173, 2000.

68. Schwartz E. Moskovitz A.,Potasman I., Peri G., Grossman Z., Alkan M.L. The changing epidemiology of dengue fever in travelers to Thailand. Eur.J.Clinical Microbiology .& Infectious Diseases. 19, 784-786, 2000

69. Schwartz E. Study of Dengue Fever among Israeli Travellers to Thailand WHO, Dengue Bulletin, 26; 162-167, 2002

70. Wilder-Smith A, Schwartz E. Dengue in travelers. New Engl. J. Med – 353:924-32, 2005

71. Tanai A, Schwartz E., Bin H., Zeller H, Niedrig M, Dan M. Chikungunia fever in Israeli travelers returning from north-western India J. of Travel Medicine , 2008 ;15(5):382-4

72. Eli Schwartz, Leisa Weld, Wilder-Smith A, von Sonnenburg F, Keystone JS, Kain KC, Torresi J, and Freedman DO for the GeoSentinel Surveillance Network. Seasonality, Annual Trends, and Characteristics of Dengue in Ill Returned Travelers. Emerging Infectious Diseases.. 2008 ;14(7):1081-8.

73. Meltzer E, Schwartz E., A travel medicine view of Dengue and Dengue hemorrhagic fever Trop Med Inf Dis- (5):278-83. 2009 (Review).

74. Leshem E, Bin H, Shalom U, Perkin M, Schwartz E Risk for Dengue and Chikungunya in Israel Emerging Infectious Diseases, 18(2):345-7, 2012

75.Meltzer E, Bin H. Schwartz E Capillary leakage in Travelers with Dengue Infection : Implications for pathogenesis Am J Trop Med Hyg. 2012

Viral hepatitis:

76. Schwartz E., Shlim D.R., Innis B., Eaton M. Viral hepatitis in foreign residents and travellers in Nepal. J. of Wilderness Medicine. 2, 88-93, 1991.

-8 - Short CV- ELI SCHWARTZ, MD, DTMH

77. Schwartz E., Yaron I., Galun E. Hepatitis E virus (review). Harefu'ah 127, 149-151, 1994.

78. Schwartz E., Galun E. Prior hepatitis A virus infection enhances acute hepatitis E virus infection. Medical Hypothesis, 42, 198-202, 1994.

79. Karetnyi Y.V., Favorov M.O., Khudyakova N.S., Weiss P., Bar-Shani S., Handsher R., Aboudy Y., Varsano N., Schwartz E., Levin E., Mendelson E., Fields H.A. Serological evidence for hepatitis E infection in Israel. J. of Medical Virology. 45, 316-320, 1995.

80. Schwartz E., Raveh D. The prevalence of hepatitis A antibodies among Israeli travelers and the economic feasibility of screening before vaccination International J. of Epidemiology. 27, 118-120, 1998.

81. Schwartz E., Piper-Jenks N. Simultaneous amebic liver abscess and hepatitis A infection. J. of Travel Medicine. 5, 95-96, 1998.

82. Schwartz E., Piper-Jenks N. Van damme P., Galun E. Hepatitis E virus infection among travelers. Clinical Infectious Disease. 29, 1312-1314, 1999.

83. Piper-Jenks N. Horowitz H. Schwartz E. The risk of hepatits E virus infection among travelers. J. of Travel Medicine. 7, 194-99, 2000 (see attached Editorial on it)

Others:

84. Shlim D.R., Schwartz E., Houston R. Rabies immunoprophylaxis strategy in travelers. J. of Wilderness Medicine. 2, 15-21, 1991.

85. Gautret P, Schwartz E, Shaw M, Soula G, Gazin P. Delmont J , Parola P , Soavi JM, Matchett E, Brown G and Torresi J for the GeoSentinel Surveillance Network. Animal-associated injuries and related diseases among returned travellers: A review of the GeoSentinel Surveillance Network Vaccine- 25;2656-2663, 2007

-9 - Short CV- ELI SCHWARTZ, MD, DTMH

Bacterial Infection

Typhoid Fever:

86. Schwartz E., Shlim D.R., Eaton M., Jenks N., Houston R. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Archives of Internal Medicine. 150, 349-51, 1990.

87. Schwartz E., Shlim D.R. Enteric fever among Israeli travellers in Nepal: The need for typhoid vaccination. Israel. J. of Medical Science. 26, 325-27, 1990.

88. Schwartz E. Typhoid vaccine - a double-edged sword? Israel. J. of Medical Science. 26, 645-46, 1990

89. Schwartz E., Piper Jenks N., Shlim DR., Typhoid hepatitis or typhoid fever and acute viral hepatitis. Transactions of the Royal Society of Tropical Medicine and Hygiene.88:437-438, 1994.

90. Shlim D.R., Schwartz E., Eaton M. Clinical importance of Salmonella paratyphi A infection to enteric fever in Nepal. J. of Travel Medicine 2, 1665-168, 1996.

91. Meltzer E., Sadik C, Schwartz E. Enteric Fever in Israeli Travelers: a Nation-Wide study J. of Travel Medicine – 12:275-81 , 2005

92. Meltzer E. Yosipovitch O., Sadik C., Dan M, Schwartz E. Epidemiology and clinical aspects of Typhoid Fever in Israel. American . J. of Tropical Medicine and Hygiene 74; 540-45, 2006

93. Meltzer E, Schwartz E. Typhoid fever in Israel (Review) Isr Med Assoc J. 9:736–741, 2007

94. Connor BA, Schwartz E. Typhoid and paratyphoid fever in Travellers The Lancet Infectious Diseases-5,623-8, 2005

95. Meltzer E, Schwartz E. Enteric fever: an Israeli perspective (Review)

-10 - Short CV- ELI SCHWARTZ, MD, DTMH

Isr Med Assoc J. 9:736–741, 2007

96. Schwartz E. Connor BA. Typhoid infection. BMJ Point-of-Care ;2008 www.pointofcare.bmj.com

97. Galmor O, Suez J, Elhadad D, Porwollik S, Leshem E, Valinsky L, McClelland M, Schwartz E, Rahav G. Molecular and Cellular Characterization of a Salmonella enterica Serovar Paratyphi A outbreak Strain and the Human Immune Response to its Infection. Clinical & Vaccine Immunology 2012

Spirochete (Leptospirosis & Relapsing Fever)

98. Kariv R, Klempfner R., Barnea A. Sidi Y, Schwartz E. The changing epidemiology of leptospirosis in Israel. Emerging Infectious Diseases. 7; 990- 992, 2001

99. Hadad E.,Pirogovsky A, Bartal C, Gilad J, Barnea A, Itzhaki S, Grotto I, Balicer R, Schwartz E. Leptospirosis among Israeli troops trained in the Jordan river. American . J. of Tropical Medicine and Hygiene –74: 127-31, 2006

100. Sidi G, Balicer R, , Davidovitch N, Anis E, Grotto I, Schwartz E. The Epidemiology of Tick-Borne Relapsing Fever in Israel Emerging Infectious Diseases. 11; 1784-6, 2005

101. Hadad E.,Pirogovsky A, Bartal C, Gilad J, Barnea A, Itzhaki S, Grotto I, Balicer R, Schwartz E. Leptospirosis among Israeli troops trained in the Jordan river. American . J. of Tropical Medicine and Hygiene –74: 127-31, 2006

102. Sidi G, Balicer R, , Davidovitch N, Grotto I, Schwartz E. Tick-Borne Relapsing Fever in Israeli Defence Forces J. Israel Miltary Medicine., 3; 51-55, 2006

103. Leshem E, Segal G, Barnea A, Yitzhaki S. , Ostfeld I , Pitlik S, Schwartz E. Travel-Related Leptospirosis in Israel: A Nationwide Study Am J Trop Med Hyg. 2010- In press

Others:

104. Fanny D., Thomas L., Schwartz E.

-11 - Short CV- ELI SCHWARTZ, MD, DTMH

An outbreak of pyomyositis in a large refugee camp in Thailand. American . J. of Tropical Medicine and Hygiene. 33: 131-133, 1982.

105. Somekh E., Lev B., Schwartz E., Barzilai A., Rubinstein E. The effect of ciprofloxacin and pefloxacin on bone marrow engraftment in the spleen of mice. J. of Antimicrobial Chemotherapy. 23:247-51, 1989

106. Moualem M., Friedman E., Pausner R., Schwartz E., Rubinstein E.: Rickettsiosis- associated hyponatremia. Infection 15,5: 315-316, 1987.

107. Schwartz E, Bar-El D, Schur N. The History of Cholera Epidemics in Israel Harefuah,-144:, 363-70, 2005

108. Jensenius M, Davis X, Sonnenburg F, Schwartz E,. Keystone JS, Leder K, Lopéz- Véléz R, Caumes E,. Cramer JP, Chen L, Parola P, for the GeoSentinel Surveillance Network* Rickettsial diseases in international travellers: the GeoSentinel experience 1996- 2008 Emerging Infectious Diseases.. 2009

109. Meltzer E, Sidi Y, Smolen G, Banai M, Schwartz E Sexually transmitted Brucellosis in humans Clin Infect Dis. 2010 –in press

110. Atias D, Meltzer E, Leshem E, Schwartz E. Rickettsia africae infection among participants in a women's safari to South Africa]. Harefuah. 2010 Sep;149(9):572-5, 620. Hebrew.

111. Leshem E, Meltzer E, Schwartz E Travel-associated zoonotic bacterial diseases Curr Opin Infect Dis. 24(5):457-63, 2011.

112. Neuberger A, Schwartz E, Clostridium difficile infection after malaria chemoprophylaxis with doxycycline: Is there an association? Travel Medicine and Infectious Disease 9(5):243-5 , 2011

International Missions

113. Schwartz E., Pener H., Issa M.S., Golenser J. An overview of the malaria situation in Zanzibar. J. of Community Health 22, 33-44, 1997.

-12 - Short CV- ELI SCHWARTZ, MD, DTMH

114. Schwartz E., Paul F., Pener H., Almog S., Rotenberg M., Golenser J. Malaria antibodies and mefloquine levels among United Nations troops in Angola. J. Travel Medicine. 8:113-116, 2001

115. Schwartz E. Help Tsunami Victims – be a Tourist! J. of Travel Medicine , 12; 120-21, 2005

116. Schwartz E. The aftermath of the Tsunami Harefuah,- 144: 160-162, 2005

117. Katz U, Zilberman N, Rusinek I, Schwartz E Israeli mission to Equatorial Guinea during a cholera outbreak Harefuah,-, 144:, 306-9, 2005

118. Katz U, Zilberman N, Rusinek I, Schwartz E Caring for the Care-givers J. of Travel Medicine , 13; 63-6, 2006

119. Neuberger A., Tenenboim S, Golos M, Pex R, Krakowsky Y, Urman M, Vernet S, Schwartz E. Infectious diseases seen in a primary care clinic in Leogane, Haiti Am J Trop Med Hyg. 86(1):11-5, 2012

Travel Medicine –Epidemiology & general 120. The GeoSentinel Group. Geosentinel:The Global Emerging Infections Sentinel Network of the International Society of Travel Medicine. J. of Travel Medicine. 6: 94-98, 1999.

121. Alkan M.L., Hermesh H., Simerman J., Atzmon B., Peri G., Schwartz E.. Severe psychiatric disorders during trips to the Far East. Harefu’a . 136, 940-942, 1999.

122. Schwartz E. Witztum E., Mumcuoglu K.Y Travel as a trigger for shared delusional parasitosis. Travel Medicine. 8;26-28, 2001

123. M.E. Wilson, Eli Schwartz Fever in returening travelers. (Chapter) In: Keystone JS, ed. Travel Medicine. Edinburgh: Mosby 2004

124. Steinlauf S, Segall G, Sidi Y, Schwartz E Epidemiology of Travel -Related Hospitalization J. of Travel Medicine – 12: 136-141, 2005

-13 - Short CV- ELI SCHWARTZ, MD, DTMH

125. Wilson ME, Weld L Boggild A, Keystone JS., Kain KC, Sonnenburg F, Schwartz E for the GeoSentinel Surveillance Network Fever in Returned Travelers :Results from the GeoSentinel Surveillance Network Clinical Infectious Diseases-, 44 (12) 1560-8. 2007

126. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS; GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. ;354:119-30. 2006

127. Wilson ME, Weld L Boggild A, Keystone JS., Kain KC, Sonnenburg F, Schwartz E Fever in Returned Travelers :Results from the GeoSentinel Surveillance Network Clinical Infectious Diseases-, 44 (12) 1560-8. 2007

128. Greenwood Z , Black J Weld L, O’Brien D, Leder K, Von Sonnenburg F, Pandey P, Schwartz E, Connor B, Brown G, Freedman D, Torresi J, for the GeoSentinel Surveillance Network. Gastrointestinal Infection Among International Travelers Globally J. of Travel Medicine , 15(4):221-8. ; 2008

129. Lederman E, Weld L, Elyazar I, Kes M , Sonnenburg F, Loutan L, Schwartz E. Keystone J. Dermatologic Conditions of the Ill Returned Traveler: An Analysis from the GeoSentinel Surveillance Network” Int J Infect Dis. 12(6):593-602; 2008

130. Leshem E, Pandey P.,. Shlim DR, Hiramatsu K, Sidi Y , Schwartz E Clinical Features of Patients with Severe Altitude Illness in Nepal J. Travel Med- 15(5):315-22. 2008

131. Nicolls DJ., Weld L, Schwartz E , Reed C, Sonnenburg F, Kozarsky P, for the GeoSentinel Surveillance Network Schistosomiasis in Travelers: a review of patients reported to the GeoSentinel Surveillance Network. Am J Trop Med Hyg. 79(5):729-34. 2008

132. Steinlauf S, Yahalom, Schwartz E , Shinar E, Segal G, Sidi Y Epidemiology of HTLV1 infection among blood donors in Israel: A Global Implication? Emerging Infectious Diseases.. 15(7):1116-8. 2009

133. Hagmann S, , Neugebauer R, , Schwartz E, Perret C, Castelli F, Barnett E, Stauffer WM., for the GeoSentinel Surveillance Network* Illness in Children after International Travel:Analysis from the GeoSentinel Surveillance Network Pediatrics -accepted

-14 - Short CV- ELI SCHWARTZ, MD, DTMH

134. Chen LH., Wilson ME., Davis X, Loutan L, Schwartz E, Keystone J, Hale D, Lim PL, McCarthy A, Gkrania-Klotsas E, Schlagenhauf P, for the GeoSentinel Surveillance Network Risk of illness in long-term travelers presenting to the GeoSentinel Surveillance Network Emerging Infectious Diseases.. 15(11):1773-82. 2009

135. Schlagenhauf P,. Chen LH,. Wilson ME , Freedman DO, Tcheng D., Schwartz E, Pandey P, Weber R, Nadal D, Berger C, Sonnenburg F, Keystone J, Leder K. Sex and Gender Differences in Travel-Associated Illness Clin Infect Dis. 50(6):826-832; 2010

136. Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME; for the GeoSentinel Surveillance Network Vaccine Preventable Diseases in Returned International Travelers: Results from the GeoSentinel Surveillance Network Vaccine 2010 – 28(46):7389-95

137. Levy T, Kivity S, Schwartz E. Protracted rheumatologic manifestations in travelers]. Harefuah. 2010 Sep;149(9):604-8, 618. Hebrew-Review

138. Leshem E, Schwartz E. Fever in returned travelers]. Harefuah. 2010 Sep;149(9):598-603, 618. Hebrew-Review

139. Mizrachi E, Steinlauf S, Schwartz E. Morbidity of Israeli travelers after traveling to developing countries]. Harefuah. 2010 Sep;149(9):563-7, 621. Hebrew.

140. Stienlauf S, Meltzer E, Leshem E, Rendi-Wagner P, Schwartz E. The profile of Israeli travelers to developing countries: perspectives of a travel clinic]. Harefuah. 2010 Sep;149(9):559-62, 621. Hebrew.

141. Schwartz E. Travel medicine: an emerging discipline in medicine]. Harefuah. 2010 Sep;149(9):556-8. Hebrew-Editorial

142. Kivity S, Meltzer E, Bin H, Schwartz E. Protracted rheumatic manifestations in travelers. J Clin Rheumatol. 2011 Mar;17(2):55-8.

143. Ben-Horin S, Bujanover Y, Goldstein S, Nadler M, Lang A, Kopylov U, Katz L, Lahat A, Schwartz E, Avidan B Travel associated health risks for patients with inflammatory bowel disease

-15 - Short CV- ELI SCHWARTZ, MD, DTMH

Clinical Gastroenterology and Hepatology 10(2):160-165 2012

144. Esposito DH, Han PV, Kozarsky PE, Walker PF, Gkrania-Klotsas E, Barnett ED, Libman M, McCarthy AE, Field V, Connor BA, Schwartz E, MacDonald S, Sotir MJ; GeoSentinel Surveillance Network Characteristics and spectrum of disease among ill returned travelers from pre- and post- earthquake Haiti: The GeoSentinel experience. Am J Trop Med Hyg. 86:23-8 2012

145. Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME; for the GeoSentinel Surveillance Network Latitudinal Patterns of Travel Among Returned Travelers with Influenza: Results from the GeoSentinel Surveillance Network, 1997 —2007 J. Travel Med 19(1):4-8, 2012

-16 -